Graftable Overview
- Year Founded
-
2022
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Graftable General Information
Description
Developer of regenerative medicines designed to optimize skin and soft tissue healing and prevent scar formation. The company offers technology for accelerated wound healing, scar reduction, support for cell transplants, and treatments for burns and radiation injuries, enabling surgeons and healthcare providers to improve tissue regeneration and enhance treatment outcomes.
Contact Information
Website
www.graftablebio.comCorporate Office
- Philadelphia, PA 60000
- United States
Corporate Office
- Philadelphia, PA 60000
- United States
Graftable Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 27-May-2026 | Completed | Out of Business | |||
| 3. Grant | 28-May-2024 | Completed | Startup | |||
| 2. Accelerator/Incubator | 13-Sep-2023 | Completed | Startup | |||
| 1. Grant | 01-Jan-2023 | $100K | Completed | Startup |
Graftable Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Graftable FAQs
-
When was Graftable founded?
Graftable was founded in 2022.
-
Where is Graftable headquartered?
Graftable is headquartered in Philadelphia, PA.
-
What industry is Graftable in?
Graftable’s primary industry is Biotechnology.
-
Is Graftable a private or public company?
Graftable is a Private company.
-
What is Graftable’s current revenue?
The current revenue for Graftable is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
